136 related articles for article (PubMed ID: 11495677)
21. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues.
Leung WK; Yu J; Chan FK; To KF; Chan MW; Ebert MP; Ng EK; Chung SC; Malfertheiner P; Sung JJ
J Pathol; 2002 Aug; 197(5):582-8. PubMed ID: 12210076
[TBL] [Abstract][Full Text] [Related]
22. Specific secretion of gel-forming mucins and TFF peptides in HT-29 cells of mucin-secreting phenotype.
Gouyer V; Wiede A; Buisine MP; Dekeyser S; Moreau O; Lesuffleur T; Hoffmann W; Huet G
Biochim Biophys Acta; 2001 May; 1539(1-2):71-84. PubMed ID: 11389969
[TBL] [Abstract][Full Text] [Related]
23. Effects of the three neuropeptides, vasoactive intestinal peptide, substance P, and calcitonin gene related peptide on basal and stimulated calcitonin release in the rat.
Månsson B; Ahrén B; Nobin A
Acta Endocrinol (Copenh); 1987 Jul; 115(3):297-300. PubMed ID: 2441551
[TBL] [Abstract][Full Text] [Related]
24. Epithelial proliferation, cell death, and gene expression in experimental colitis: alterations in carbonic anhydrase I, mucin MUC2, and trefoil factor 3 expression.
Renes IB; Verburg M; Van Nispen DJ; Taminiau JA; Büller HA; Dekker J; Einerhand AW
Int J Colorectal Dis; 2002 Sep; 17(5):317-26. PubMed ID: 12172925
[TBL] [Abstract][Full Text] [Related]
25. Functional coupling between the active transport of glucose and the secretion of intestinal neurotensin in rats.
Dakka T; Cuber JC; Chayvialle JA
J Physiol; 1993 Sep; 469():753-65. PubMed ID: 7505826
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylation of beta-catenin and epidermal growth factor receptor by intestinal trefoil factor.
Liu D; el-Hariry I; Karayiannakis AJ; Wilding J; Chinery R; Kmiot W; McCrea PD; Gullick WJ; Pignatelli M
Lab Invest; 1997 Dec; 77(6):557-63. PubMed ID: 9426392
[TBL] [Abstract][Full Text] [Related]
27. Expression of intestinal trefoil factor in developing rat intestine.
Lin J; Holzman IR; Jiang P; Babyatsky MW
Biol Neonate; 1999 Aug; 76(2):92-7. PubMed ID: 10393993
[TBL] [Abstract][Full Text] [Related]
28. Luminal glucagon-like peptide-1(7-36) amide-releasing factors in the isolated vascularly perfused rat colon.
Plaisancié P; Dumoulin V; Chayvialle JA; Cuber JC
J Endocrinol; 1995 Jun; 145(3):521-6. PubMed ID: 7636436
[TBL] [Abstract][Full Text] [Related]
29. Cyclic AMP-mediated release of peptide YY (PYY) from the isolated perfused rabbit distal colon.
Ballantyne GH; Goldenring JR; Savoca PE; Kranz HK; Adrian TE; Bilchik AJ; Modlin IM
Regul Pept; 1993 Sep; 47(2):117-26. PubMed ID: 7694325
[TBL] [Abstract][Full Text] [Related]
30. TFF peptides in the human efferent tear ducts.
Paulsen FP; Hinz M; Schaudig U; Thale AB; Hoffmann W
Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3359-64. PubMed ID: 12407144
[TBL] [Abstract][Full Text] [Related]
31. Effect of VIP and PACAP on basal release of serotonin from isolated vascularly and luminally perfused rat duodenum.
Fujimiya M; Yamamoto H; Kuwahara A
Am J Physiol; 1998 Oct; 275(4):G731-9. PubMed ID: 9756504
[TBL] [Abstract][Full Text] [Related]
32. Ontogeny and prenatal expression of trefoil factor 3/ITF in the human intestine.
Lin J; Nadroo AM; Chen W; Holzman IR; Fan QX; Babyatsky MW
Early Hum Dev; 2003 Apr; 71(2):103-9. PubMed ID: 12663147
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic spasmolytic polypeptide, a potential growth factor for the intestine: neural control of secretion.
Rasmussen TN; Thim L; Raaberg L; Harling H; Holst JJ
Digestion; 1990; 46 Suppl 2():226-31. PubMed ID: 2262056
[TBL] [Abstract][Full Text] [Related]
34. Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis.
Tran CP; Cook GA; Yeomans ND; Thim L; Giraud AS
Gut; 1999 May; 44(5):636-42. PubMed ID: 10205199
[TBL] [Abstract][Full Text] [Related]
35. Neuropeptide modification of chloride secretion in guinea pig distal colon.
McCulloch CR; Kuwahara A; Condon CD; Cooke HJ
Regul Pept; 1987 Oct; 19(1-2):35-43. PubMed ID: 2446352
[TBL] [Abstract][Full Text] [Related]
36. Solution structure of the disulfide-linked dimer of human intestinal trefoil factor (TFF3): the intermolecular orientation and interactions are markedly different from those of other dimeric trefoil proteins.
Muskett FW; May FE; Westley BR; Feeney J
Biochemistry; 2003 Dec; 42(51):15139-47. PubMed ID: 14690424
[TBL] [Abstract][Full Text] [Related]
37. Temporal changes in TFF3 expression and jejunal morphology during methotrexate-induced damage and repair.
Xian CJ; Howarth GS; Mardell CE; Cool JC; Familari M; Read LC; Giraud AS
Am J Physiol; 1999 Oct; 277(4):G785-95. PubMed ID: 10516144
[TBL] [Abstract][Full Text] [Related]
38. Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29.
Björk J; Nilsson J; Hultcrantz R; Johansson C
Scand J Gastroenterol; 1993 Oct; 28(10):879-84. PubMed ID: 7505479
[TBL] [Abstract][Full Text] [Related]
39. Differential behavioral effects of TFF peptides: injections of synthetic TFF3 into the rat amygdala.
Schwarzberg H; Kalbacher H; Hoffmann W
Pharmacol Biochem Behav; 1999 Jan; 62(1):173-8. PubMed ID: 9972861
[TBL] [Abstract][Full Text] [Related]
40. IL-4 and IL-13 up-regulate intestinal trefoil factor expression: requirement for STAT6 and de novo protein synthesis.
Blanchard C; Durual S; Estienne M; Bouzakri K; Heim MH; Blin N; Cuber JC
J Immunol; 2004 Mar; 172(6):3775-83. PubMed ID: 15004182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
